458 related articles for article (PubMed ID: 30805320)
21. Epstein - Barr virus positive T and NK-cell lymphoproliferations: Morphological features and differential diagnosis.
Montes-Mojarro IA; Kim WY; Fend F; Quintanilla-Martinez L
Semin Diagn Pathol; 2020 Jan; 37(1):32-46. PubMed ID: 31889602
[TBL] [Abstract][Full Text] [Related]
22. Chronic active EBV infection in refractory enteritis with longitudinal ulcers with a cobblestone appearance: an autopsied case report.
Aihara Y; Moriya K; Shimozato N; Nagamatsu S; Kobayashi S; Uejima M; Matsuo H; Ishida E; Yagi H; Nakatani T; Yoshiji H; Kikuchi E
BMC Gastroenterol; 2021 Jan; 21(1):6. PubMed ID: 33407170
[TBL] [Abstract][Full Text] [Related]
23. Chronic Active Epstein-Barr Virus Infection: The Elucidation of the Pathophysiology and the Development of Therapeutic Methods.
Arai A
Microorganisms; 2021 Jan; 9(1):. PubMed ID: 33467742
[TBL] [Abstract][Full Text] [Related]
24. Characterization and treatment of chronic active Epstein-Barr virus disease: a 28-year experience in the United States.
Cohen JI; Jaffe ES; Dale JK; Pittaluga S; Heslop HE; Rooney CM; Gottschalk S; Bollard CM; Rao VK; Marques A; Burbelo PD; Turk SP; Fulton R; Wayne AS; Little RF; Cairo MS; El-Mallawany NK; Fowler D; Sportes C; Bishop MR; Wilson W; Straus SE
Blood; 2011 Jun; 117(22):5835-49. PubMed ID: 21454450
[TBL] [Abstract][Full Text] [Related]
25. EBV induces persistent NF-κB activation and contributes to survival of EBV-positive neoplastic T- or NK-cells.
Takada H; Imadome KI; Shibayama H; Yoshimori M; Wang L; Saitoh Y; Uota S; Yamaoka S; Koyama T; Shimizu N; Yamamoto K; Fujiwara S; Miura O; Arai A
PLoS One; 2017; 12(3):e0174136. PubMed ID: 28346502
[TBL] [Abstract][Full Text] [Related]
26. A case series of CAEBV of children and young adults treated with reduced-intensity conditioning and allogeneic bone marrow transplantation: a single-center study.
Watanabe Y; Sasahara Y; Satoh M; Looi CY; Katayama S; Suzuki T; Suzuki N; Ouchi M; Horino S; Moriya K; Nanjyo Y; Onuma M; Kitazawa H; Irie M; Niizuma H; Uchiyama T; Rikiishi T; Kumaki S; Minegishi M; Wada T; Yachie A; Tsuchiya S; Kure S
Eur J Haematol; 2013 Sep; 91(3):242-248. PubMed ID: 23734904
[TBL] [Abstract][Full Text] [Related]
27. Clinicopathological states of Epstein-Barr virus-associated T/NK-cell lymphoproliferative disorders (severe chronic active EBV infection) of children and young adults.
Suzuki K; Ohshima K; Karube K; Suzumiya J; Ohga S; Ishihara S; Tamura K; Kikuchi M
Int J Oncol; 2004 May; 24(5):1165-74. PubMed ID: 15067338
[TBL] [Abstract][Full Text] [Related]
28. Pathogenesis of chronic active Epstein-Barr virus infection: is this an infectious disease, lymphoproliferative disorder, or immunodeficiency?
Kimura H
Rev Med Virol; 2006; 16(4):251-61. PubMed ID: 16791843
[TBL] [Abstract][Full Text] [Related]
29. Chronic active Epstein-Barr virus infection progresses to aggressive NK cell leukemia with a poor prognosis.
Hu X; Yang Y; Chen L; Wan Y; Sheng L; Bao Y; Zheng M
Am J Transl Res; 2021; 13(10):12006-12015. PubMed ID: 34786135
[TBL] [Abstract][Full Text] [Related]
30. Epstein-Barr Virus-Associated T and NK-Cell Lymphoproliferative Diseases.
Kim WY; Montes-Mojarro IA; Fend F; Quintanilla-Martinez L
Front Pediatr; 2019; 7():71. PubMed ID: 30931288
[TBL] [Abstract][Full Text] [Related]
31. Successful control of Epstein-Barr virus (EBV)-infected cells by allogeneic nonmyeloablative stem cell transplantation in a patient with the lethal form of chronic active EBV infection.
Uehara T; Nakaseko C; Hara S; Harima A; Ejiri M; Yokota A; Saito Y; Nishimura M
Am J Hematol; 2004 Aug; 76(4):368-72. PubMed ID: 15282671
[TBL] [Abstract][Full Text] [Related]
32. Epstein-Barr virus-associated T- and NK-cell lymphoproliferative diseases: an update and diagnostic approach.
Hue SS; Oon ML; Wang S; Tan SY; Ng SB
Pathology; 2020 Jan; 52(1):111-127. PubMed ID: 31767131
[TBL] [Abstract][Full Text] [Related]
33. Chronic Active Epstein-Barr Virus Infection of T/NK-Cell Type Mimicking Classic Hodgkin Lymphoma: Clinicopathologic and Genetic Features of 8 Cases Supporting a Variant With "Hodgkin/Reed-Sternberg-like" Cells of NK Phenotype.
Chen Z; Liu W; Zhang W; Ye Y; Guan P; Gao L; Zhao S
Am J Surg Pathol; 2019 Dec; 43(12):1611-1621. PubMed ID: 31305266
[TBL] [Abstract][Full Text] [Related]
34. Epstein-Barr Virus-Associated γδ T-Cell Lymphoproliferative Disorder Associated With Hypomorphic
Tanita K; Hoshino A; Imadome KI; Kamiya T; Inoue K; Okano T; Yeh TW; Yanagimachi M; Shiraishi A; Ishimura M; Schober T; Rohlfs M; Takagi M; Imai K; Takada H; Ohga S; Klein C; Morio T; Kanegane H
Front Pediatr; 2019; 7():15. PubMed ID: 30778380
[TBL] [Abstract][Full Text] [Related]
35. [Virus-specific cytotoxic T cells in chronic active Epstein-Barr virus infection].
Shibayama H; Imadome KI; Onozawa E; Tsuzura A; Miura O; Koyama T; Arai A
Rinsho Ketsueki; 2017; 58(6):583-588. PubMed ID: 28679986
[TBL] [Abstract][Full Text] [Related]
36. NK-cell post-transplant lymphoproliferative disease successfully treated by second allogenic hematopoietic stem cell transplantation in chronic active Epstein-Barr virus infection.
Shibata S; Takiuchi Y; Kawasaki N; Okamoto Y; Inano S; Fukunaga A; Tabata S; Arai A; Imadome KI; Kitano T
Int J Hematol; 2022 Apr; 115(4):595-599. PubMed ID: 35001347
[TBL] [Abstract][Full Text] [Related]
37. The superiority of Epstein-Barr virus DNA in plasma over in peripheral blood mononuclear cells for monitoring EBV-positive NK-cell lymphoproliferative diseases.
Zheng M; Bao Y; Wang J; Ma Y; Yang Y; Zhang P; Chen L; Zheng K; Zhou J
Hematol Oncol; 2022 Aug; 40(3):381-389. PubMed ID: 35405763
[TBL] [Abstract][Full Text] [Related]
38. Clinicopathological analysis of the age-related differences in patients with Epstein-Barr virus (EBV)-associated extranasal natural killer (NK)/T-cell lymphoma with reference to the relationship with aggressive NK cell leukaemia and chronic active EBV infection-associated lymphoproliferative disorders.
Takahashi E; Ohshima K; Kimura H; Hara K; Suzuki R; Kawa K; Eimoto T; Nakamura S;
Histopathology; 2011 Oct; 59(4):660-71. PubMed ID: 22014047
[TBL] [Abstract][Full Text] [Related]
39. Interferon alpha as antiviral therapy in chronic active Epstein-Barr virus disease with interstitial pneumonia - case report.
Roliński J; Grywalska E; Pyzik A; Dzik M; Opoka-Winiarska V; Surdacka A; Maj M; Burdan F; Pirożyński M; Grabarczyk P; Starosławska E
BMC Infect Dis; 2018 Apr; 18(1):190. PubMed ID: 29678144
[TBL] [Abstract][Full Text] [Related]
40. Epstein-Barr virus-associated B-cell lymphoproliferative disorder meeting the definition of CAEBV B cell disease: a case report.
Ma Y; Bao Y; Zheng M
BMC Infect Dis; 2023 Jul; 23(1):453. PubMed ID: 37420238
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
